De Novo device
QuantX
Quantitative Insights, Inc. · Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK, Class II) · First FDA decision Jul 19, 2017, newest Jul 19, 2017Breast cancerCancer detection and genomic testingThyroid nodules and thyroid disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
0
Naming "QuantX"
MAUDE reports
1
Brand "QuantX", since 2015
PubMed studies
1
Mentioning "QuantX"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing QuantX
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- QuantXNew device typeDe Novo
DEN170022 · Decided Jul 19, 2017 · 103 days after receipt
Device type: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "QuantX", any status and sponsor, newest update first.
No registered device study names "QuantX".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "QuantX", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code POK
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
- QUANTXMalfunction
MW5098869 · Received Jan 15, 2021 · Event dated Dec 18, 2020
Device type: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK)
Device problem as coded: Image Display Error/Artifact; Application Program Freezes or Fails to Launch
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "QuantX"[tiab]. The summary above synthesizes these.
- A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer.
Jimenez JE, Abdelhafez A, Mittendorf EA, et al. · Eur J Radiol · 2022
Other devices of this type
Also filed under product code POK.
- Koios DS (3.8)Koios Medical, Inc. · 510(k) 2026
- Fetal EchoScan (v1.2)Brightheart · 510(k) 2025
- Sonio SuspectSonio · 510(k) 2026
- Brainomix 360 e-ASPECTSBrainomix Limited · 510(k) 2025
- Rapid ASPECTS (v3)Ischemaview, Inc. · 510(k) 2024
- BlineSlideDeep Breathe, Inc. · 510(k) 2026
- Automated Aortic Stenosis Software (AutoAS)GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · 510(k) 2026
- RevealAI-LungPrecision Medical Ventures, Inc. Dba Revealdx · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.